On April 1, 2026, the Lucknow-based Small Industries Development Bank of India (SIDBI) medical director Dr. Arvind Kapoor told a press conference that every transplant patient admitted after that date would fall under the new ₹15 lakh cap enforced by 12 general insurers, including ICICI Lombard and HDFC Ergo. “Patients book beds at Apollo Bangalore on March 31 thinking they’re safe,” he said. “By April 2, we’re told the ₹72 lakh bill is on us.” Apollo Hospitals Bengaluru confirmed to The Hindu that 112 of its 380 transplant cases scheduled after March 31 had been deferred because no insurer would cover the difference between the ₹15 lakh cap and the ₹45 lakh to ₹78 lakh that such surgeries now demand.
Medanta The Medicity in Gurgaon received 87 transplant requests between February 15 and March 25. Of those, 43 cases were cancelled after United India Insurance wrote April 26 letters declining further liability. Dr. Rajesh Goyal, Medanta’s chief transplant surgeon, told reporters on March 28 that two heart-transplant families had borrowed ₹22 lakh from relatives to keep patients alive while they raced to file complaints. “United India’s letter cited ‘revised IRDAI guidelines April 2026’,” he said, “but the circular only sets a reporting benchmark, not a coverage cap.”
The ₹15 lakh glitch first surfaced on March 19 when Apollo Group’s Health Plus (₹50 lakh base cover) policyholders received flash SMSes warning that any transplant claim filed between April 1 and August 31 would trigger a sub-limit of ₹15 lakh. This was not mentioned in the 2025 brochure. Ashok Srinivasan, a 58-year-old Hyderabad businessman whose kidney-transplant pre-authorisation was approved on March 22, was told on April 3 that the ₹43 lakh hospital bill would be adjusted against his ₹50 lakh policy—leaving ₹7 lakh uncovered. “The agent said ‘only ₹15 lakh is eligible under new sub-limits’,” he said. Apollo Group’s customer-care executive, Priya Menon, confirmed the SMS to the Indian Express on March 26.
The new restriction spread like wildfire. By April 2, Fortis Escorts Heart Institute in Delhi had 31 open liver and lung cases that they could no longer schedule. Dr. Sanjay Mittal, director of cardiac sciences, noted that insurers like Bajaj Allianz and Reliance Health had begun “silent renewals” that exclude transplant coverage rather than notify patients. That Tuesday evening, the Insurance Regulatory and Development Authority of India (IRDAI) issued an FAQ stating that existing policies do not get reduced caps—only new issuances after April 1 would. The FAQ did not clarify whether mid-term renewals count as “new issuances.”
Patient advocates are furious. Mumbai-based advocate Rohit Nair filed a public-interest litigation in the Bombay High Court on April 3 asking for ₹22 lakh deposits collected from 212 policyholders be returned immediately. “The IRDAI circular dated March 15 did not impose any cap,” he argued in court papers. “Yet Apollo and ICICI Lombard applied the ₹15 lakh sub-limit retroactively.” The court scheduled an urgent hearing for April 8.
Meanwhile, the Transplant Coordinators Association (TCA) of India reported 412 patients across eight cities who were admitted on March 31 but given discharge slips on April 2 for non-payment. Fortis Bangalore’s billing manager, Aravind Kumar, said April 4 that 17 gastrectomy-related transplants are now pending, each incurring ₹18,000 daily bed charges. “Patients who cannot pay,” he said, “are lying on stretchers in corridors.”
And insurers are dug in. ICICI Lombard spokeswoman Kavita Choudhary emailed a statement on April 1 saying the ₹15 lakh cap is “in line with revised government healthcare benchmarks effective April 2026.” HDFC Ergo CEO Vibha Padalkar defended the move in a Times Now interview aired April 2: “We’re aligning national median cost data, not arbitrary cuts; heart transplants now average ₹58 lakh nationwide.” Neither executive clarified why the cap skips older policies still in force.
In Bangalore, Jyothi Reddy’s 22-year-old son Akhil awaits a bone-marrow transplant his insurer Tata AIG declined on April 3. The family’s ₹35 lakh policy was purchased in September 2024. Tata AIG’s local agent in Marathahalli told them the cap applies “to all policies post-March 15 renewal notices.” Jyothi called this “retroactive exploitation.” Tata AIG did not respond to multiple requests for comment.
The Finance Ministry stepped in on April 5, directing all Public Sector General Insurance companies to immediately restore the ₹50 lakh transplant coverage they offered until March 31. The order, stamped “File No. 13-2/2026-H”, did not bind private insurers. Apollo Group’s shares fell 4.2% on April 7 after the order.
Experts say the chaos will linger until IRDAI mandates a uniform ₹50 lakh minimum transplant cover for all retail health insurance policies sold or renewed after August 31, 2026. Dr. Kapoor of SIDBI predicts “at least 1,200 transplant patients will face gaps this year,” adding that 60% are low-income families who cannot bridge ₹40 lakh shortfalls. He urged the government to subsidise short-term bridge loans.
But the Insurers Association of India (IAI) secretary general, Sandeep Batra, told the Economic Times on April 6 that expanding coverage would raise premiums by 22%, pushing policies beyond ₹85,000 a year. “Affordability will suffer,” he claimed.
The next hearing at the Bombay High Court is set for April 8. Until then, over 400 Indians remain either in hospital corridors or boarding wards waiting for coverage that no longer exists.
